CNoga Medical Raises $12.5M

October 28, 2014 | The Israeli company CNoga Medical, developing a non-invasive diagnosis method for diabetes, completed a $12.5 million financing round from Chinese investment fund GoCapital. CNoga’s device uses the patient’s skin color to diagnose high blood pressure and a method for measuring blood sugar without puncturing the skin. Currently, CNoga’s blood pressure measuring device has received market approval in the US and Europe, and the diabetes product only in Europe. CNoga was founded in 2004 by Dr. Yosef Segman, the founder of OPlus Technologies that sold to Intel in 2005, and in 2007 signed a cooperation agreement with Texas Instruments.